Lunaphore
Media & Entertainment · Cinema
$70.6Mtotal raised · 2 rounds on record
$44.8Mlatest round · Series D · Mar 2023 · 3 yr ago
2backers · Occident, Redalpine
21stories in the press
Overview
Lunaphore Technologies is a spatial biology company based in Tolochenaz near Lausanne, Switzerland, that builds instruments and reagents for multiplex immunofluorescence and immunohistochemistry, including the COMET platform and SPYRE antibody panels for discovery and immuno-oncology research. The company was acquired by the US life sciences group Bio-Techne, and it now operates together with Advanced Cell Diagnostics under the Bio-Techne Spatial name. Its work draws on engineers, assay developers, applications scientists and field specialists who develop, manufacture and support the COMET instrument and its reagents for research customers.
Funding and backers
Total raised
$70.6M
2 rounds on record
Latest round
$44.8M
Series D · Mar 2023 · 3 yr ago
Backers
2
Occident, Redalpine
The money's age
Long since its last round
43 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 26, 2024
Partnership Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research · lunaphore.com
Mar 28, 2024
Partnership Lunaphore and Nikon Instruments Inc. announce partnership to expand access to innovative spatial biology services · lunaphore.com
Mar 23, 2023
Raised a round Series D $44.8M · led by EGS Beteiligungen AG
Feb 6, 2020
Raised a round Series C $25.8M · led by PHC Holdings Corporation · Venturebeat
2014
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | Mar 2023 | $44.8M | EGS Beteiligungen AG lead | businesswire.com |
| Series C | Feb 2020 | $25.8M | PHC Holdings Corporation lead | Venturebeat |
Registers and programsofficial lists and records that name the company
| Legal entity | Lunaphore Technologies S.A. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Redalpine Investors in similar startupsfunds that back the companies most like this one
backs Cultura Colectiva
Similar startupsby what they do, their industry and backers
X-ZELL connects Cryosuite workflows, Cryophore multiplex panels, verified antibodies, cytology reagents, evidence resources, and OEM…
Direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens.
An ultrasensitive immunoassay platform with multiplex capability and broad dynamic range – without giving up the ELISA workflow your lab…
Company Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Company History Investors Science Biology…
En Cultura Colectiva ¡Descubre lo último en moda, cine, deportes, tecnología y mucho más!
Kino is a collaborative video editor. Share your timeline as a URL, search every frame by meaning, and edit with AI.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
OccidentVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Bio-Techne partners with the Wyss Center Geneva to advance automated 3D multiomics technology and accelerate spatial biology
- Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers. - Innovation has the potential to improve preclinical research by reducing reliance on animal testing through New Approach Metho
Read more
Report
AI-powered spatial biology workflow from Bio-Techne and Nucleai enables predictive biomarker discovery in melanoma patients
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy and targeted therapy-treated melanoma patients. Bio-Techne's COMET platform and
Read more
Report
Balancing sensitivity and throughput with multiplex immunoassays
The post Balancing sensitivity and throughput with multiplex immunoassays appeared first on Lunaphore Technologies.
Read more
Report
Lunaphore COMET platform paves the way for spatial biology adoption in clinical research
MINNEAPOLIS, MN - November 05, 2024 - Bio-Techne Corporation (NASDAQ: TECH) today announced the release of clinically relevant spatial biology data. The data was generated using Bio-Techne's Lunaphore branded end-to-end spatial biology offering, including
Read more
Report
Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research
MINNEAPOLIS - September 26, 2024 - Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET, a best-in-class spatial biology plat
Read more
Report
One researcher's journey with spatial biology in endometriosis research
The post One researcher's journey with spatial biology in endometriosis research appeared first on Lunaphore Technologies.
Read more
Report
Spatial biology with Rodrigo Romero
The post Spatial biology with Rodrigo Romero appeared first on Lunaphore Technologies.
Read more
Report
How spatial biology is driving tumor microenvironment research
The post How spatial biology is driving tumor microenvironment research appeared first on Lunaphore Technologies.
Read more
Report
Lunaphore and Nikon Instruments Inc. announce partnership to expand access to innovative spatial biology services
MINNEAPOLIS, MN - March 28, 2024 - Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that Lunaphore, part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services w
Read more
Report
Lunaphore brings together the spatial biology community at AACR 2024 to mark innovations in cancer research
MINNEAPOLIS, MN and LAUSANNE, Switzerland - March 21, 2023 - Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brand, Lunaphore, will host an in-person symposium at the American Association for Cancer Research (AACR) Annual Me
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Lausanne
Switzerland
HQ